About KawaHive

Go-to-market strategy for MedTech and medical device founders

Regulatory clearance is a milestone, not a go-to-market strategy. Hospital interest and a distributor agreement do not automatically lead to purchase orders.

KawaHive & Partners helps MedTech and medical device founders make clearer go-to-market decisions across Asia-Pacific: which markets to prioritise, which customers to focus on and how to assess distributor effectiveness.

We work with teams that have a product and regulatory progress but need a more effective go-to-market strategy. Common issues include:

• Clinical interest that fails to convert into purchase orders
• Distributors who hold stock but generate limited sustained demand
• Uncertainty regarding priority markets or customer segments
• Strong clinical value that does not translate into commercial results

We listen first, ask focused questions, and assess the go-to-market issue. We will be clear about whether we can help. Any paid work is scoped and agreed upfront, and there is no obligation after the call.

We bring 20 years of medical device experience from companies including GE, Fujifilm, Pentax and Konica Minolta, with commercial work across Asia-Pacific.

We do not provide regulatory consulting or marketing services. We focus on customer priorities, distributor performance, positioning and go-to-market decisions.

Start with a free introductory call. If we are a fit, we’ll agree the next step together.

We help you move from symptoms to the go-to-market decisions that matter.